Tetrazolsubstituierte Arylamide

European patent · EP2592070 · In force

Register entry

Publication number
EP2592070
Application number
EP12194476
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 18, 2007
Published
May 15, 2013
Granted
Aug 31, 2016
Protection ends at the latest
Jun 17, 2027
Next annual fee due
Jun 30, 2027
IPC classes
C07D 403/12 (2006.01)
C07D 401/14 (2006.01)
C07D 401/12 (2006.01)
C07D 409/12 (2006.01)
C07D 241/12 (2006.01)
C07D 471/04 (2006.01)
C07D 491/107 (2006.01)
Priority
US 817298 P 29.06.2006
Divided from
EP07730213
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Aug 31, 2016

    Granted

    Published in Swissreg on 31.08.2016

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

Chen, Li

201612 Shanghai, CN

Dillon, Michael P.

San Francisco, CA California 94131, US

Feng, Lichun

200240 Shanghai, CN

Hawley, Ronald Charles

Glen Ridge, NJ New Jersey 07028, US

Yang, Minmin

210029 Nanjing, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.